Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Effectiveness of a 2+1 Dose Schedule Pneumococcal Conjugate Vaccination Programme on Invasive Pneumococcal Disease Among Children in Norway
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Synthesis and in Vitro Anti-Hiv-1 Evaluation of Some N-Arylsulfonyl-3-Formylindoles
Brazilian Journal of Pharmaceutical Sciences
Toxicology
Pharmaceutics
Pharmacology
Psychometric Evaluation of a New Proxy‐instrument to Assess Participation in Children Aged 3–6 Years With Visual Impairment: PAI ‐ CY 3‐6
Ophthalmic and Physiological Optics
Ophthalmology
Sensory Systems
Optometry
Stability of 2′,3′ and 3′,5′ Cyclic Nucleotides in Formamide and in Water: A Theoretical Insight Into the Factors Controlling the Accumulation of Nucleic Acid Building Blocks in a Prebiotic Pool
Physical Chemistry Chemical Physics
Theoretical Chemistry
Astronomy
Physics
Physical
Defective Glucagon-Like Peptide 1 Secretion in Prediabetes and Type 2 Diabetes Is Influenced by Weight and Sex. Chicken, Egg, or None of the Above?: Figure 1
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Inhibition of NF-κB and HIV-1 Long Terminal Repeat Transcriptional Activation by Inducible Nitric Oxide Synthase 2 Activity
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
The Host Cell MAP Kinase ERK-2 Regulates Viral Assembly and Release by Phosphorylating the P6gagProtein of HIV-1
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Α-Helix 2 in the Amino-Terminal Mad Homology 1 Domain Is Responsible for Specific DNA Binding of Smad3
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Substituted 5-(2-Allyloxybenzyliden)-2-Aminothiazol-4-Ones: Synthesis and Characteristics of NMR Spectra
Visnyk of the Lviv University. Series Chemistry
Selecting GLP-1 Agonists in the Management of Type 2 Diabetes: Differential Pharmacology and Therapeutic Benefits of Liraglutide and Exenatide
Therapeutics and Clinical Risk Management
‹
863
864
865
866
867
868
869
›